Bextra Information
What is Bextra?
Bextra® is the name under which Pfizer markets a prescription pain
medication generically called valdecoxib. Bextra has been under
much scrutiny of late because studies have shown
adverse reations with Bextra such as heart attack, stroke, sudden cardiac
death, Erythema Multiforme (EM), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis
(TEN).
- Bextra Can Cause Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
- Cases of Stevens-Johnson syndrome and toxic epidermal necrolysis caused by Bextra use have been reported to the FDA. Stevens-Johnson syndrome -- commonly referred to as Stevens-Johnson or SJS -- and toxic epidermal necrolysis, or TEN, are closely related serious skin reactions.
- FDA Orders Pfizer to Withdraw Bextra From Market
- Bextra withdrawn due to increased risks of cardiovascular problems such as heart attack and stroke, and potentially lift-threatening skin reactions such as Stevens-Johnson Syndrome.
- Study Finds Bextra Increases Heart Attack Risk By 50 Percent
- February 2005 Study Results Link COX-2 Painkillers Vioxx, Celebrex, and Bextra to Heart Attack and Stroke. In February 2005, WellPoint Inc., the nation's largest provider of health benefits, examined 7,232 patient records of people taking Vioxx, Celebrex, and Bextra, and 629,245 records for patients not taking a COX-2 drug.
- California HMO Stops Dispensing Bextra
- Kaiser Permanente, a California based HMO, hospital, and health clinic network, has stopped prescribing Bextra for at least six months, or until the FDA and/or manufacturer Pfizer can prove Bextra is safe. Kaiser is the nation's largest not-for-profit healthcare provider, serving 8.5 million people in nine states.
- Bextra May Get Black Box Warning
- In 2002, Pfizer announced in a Dear Doctor letter to health professionals that Bextra can cause a potentially life threatening drug reaction called Stevens-Johnson Syndrome. More recently, Pfizer said that the FDA may require them to put a Black Box warning on the drug's label to alert patients about the Stevens-Johnson Syndrome risk associated with the use of Bextra.
- Study Reveals Bextra Doubles Heart Attack Risk
- Patients taking Bextra in drug trials were twice as likely to have a heart attack or stroke. Study showed Bextra, an arthritis drug in the COX-2 inhibitor class, is not so different from Vioxx for heart risk.
- Bextra Class Actions
- Our law firm believes that people injured by Bextra are better served by having an individual lawsuit filed instead of joining a class action lawsuit.
- Bextra and Legal Compensation
- How to get legal compensation for a Bextra injury or Bextra death.
- Bextra Case Evaluation
|
